NDC 59651-530

Erlotinib

Erlotinib

Erlotinib is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Erlotinib Hydrochloride.

Product ID59651-530_3ecafc1e-979a-4aff-a276-18fc0b110491
NDC59651-530
Product TypeHuman Prescription Drug
Proprietary NameErlotinib
Generic NameErlotinib
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2022-06-22
Marketing CategoryANDA /
Application NumberANDA216342
Labeler NameAurobindo Pharma Limited
Substance NameERLOTINIB HYDROCHLORIDE
Active Ingredient Strength25 mg/1
Pharm ClassesKinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 59651-530-03

30 TABLET, FILM COATED in 1 BOTTLE (59651-530-03)
Marketing Start Date2022-06-22
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Erlotinib" or generic name "Erlotinib"

NDCBrand NameGeneric Name
0093-7662ErlotinibErlotinib
0093-7663ErlotinibErlotinib
0093-7664ErlotinibErlotinib
51991-890ErlotinibErlotinib Hydrochloride
51991-891ErlotinibErlotinib Hydrochloride
51991-892ErlotinibErlotinib Hydrochloride
59651-530ErlotinibErlotinib
59651-531ErlotinibErlotinib
59651-532ErlotinibErlotinib
59923-725ErlotinibErlotinib
59923-726ErlotinibErlotinib
59923-727ErlotinibErlotinib
63304-095ErlotinibErlotinib
63304-096ErlotinibErlotinib
63304-135ErlotinibErlotinib
68382-913ErlotinibErlotinib
68382-914ErlotinibErlotinib
68382-915ErlotinibErlotinib
70771-1521ErlotinibErlotinib
70771-1522ErlotinibErlotinib
70771-1523ErlotinibErlotinib
72485-217ErlotinibErlotinib hydrochloride
72485-218ErlotinibErlotinib hydrochloride
72485-219ErlotinibErlotinib hydrochloride

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.